Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 27;262(1):e230396.
doi: 10.1530/JOE-23-0396. Print 2024 Jul 1.

Oxytocin and women's health in midlife

Affiliations
Review

Oxytocin and women's health in midlife

Galit Levi Dunietz et al. J Endocrinol. .

Abstract

Menopause marks the cessation of fertility and the transition to post-reproductive years. Nearly 1 million US women experience menopause annually, but despite the significant impact it has on their physical and mental health, menopause has been insufficiently studied. Oxytocin is a neurohormone that regulates emotionality, social behaviors, and fundamental physiological systems. Localization of oxytocin receptors in the brain, reproductive tissues, bone, and heart support their role in mental health and potentially sleep, along with reproductive and cardiovascular functions. While experimental data linking oxytocin to behavior and physiology in animals are largely consistent, human data are correlative and inconclusive. As women transition into menopause, oxytocin levels decrease while their susceptibility to mood disorders, poor sleep, osteoporosis, and cardiovascular diseases increases. These concurrent changes highlight oxytocin as a potential influence on the health and mood of women along their reproductive life span. Here, we summarize experimental rodent and non-human primate studies that link oxytocin to reproductive aging and metabolic health and highlight the inconclusive findings in studies of women. Most human studies relied on a single oxytocin assessment in plasma or on intranasal oxytocin administration. The pulsatile release and short half-life of plasma oxytocin limit the validity of these methods. We discuss the need for oxytocin assessments in stable bio-samples, such as urine, and to use valid assays for assessment of associations between changing oxytocin levels and well-being across the reproductive life span. This work has the potential to guide therapeutic strategies that will one day alleviate adverse health outcomes for many women.

Keywords: cardiometabolic disease; menopause; mood disorders; reproductive aging; sleep.

PubMed Disclaimer

Conflict of interest statement

Dr. Chervin reports research funded by the NIH; royalties as an author and editor for UpToDate; consulting for Eli Lilly & Company through a contract with the University of Michigan; and service on the board of the International Pediatric Sleep Association and advisory board for the non-profit Pajama Program.

Figures

Figure:
Figure:
Central and peripheral release of oxytocin and its function in women’s body. (Created with BioRender.com) 1. Social experiences such interacting with loved ones causes oxytocin (OT) release in the hypothalamus. 2. OT in the brain regulates social behaviors via OT projections from the hypothalamus to emotional, reward and memory-related brain regions such as the amygdala, hippocampus, local projections to the hypothalamus, and nucleus accumbens. 3. Hypothalamic OT neurons project to the posterior pituitary gland and OT is released from the pituitary in a pulsatile manner into the blood. 4. OT circulates in the bloodstream and concentrations fluctuate due to pulsatile release and rapid degradation. 5. OT receptors are metabotropic G-protein coupled receptors (GPCRs). They are found throughout brain tissue, bone systems, the cardiovascular system, and the reproductive tract. 6. Estrogen secretion from the ovaries enhances OT activity via increasing OT and OT receptor expression throughout the brain and other tissue. Aging is accompanied by a decrease in estrogen levels and may lead to compromised OT signaling.

References

    1. Acevedo-Rodriguez A, Mani SK and Handa RJ (2015). “Oxytocin and Estrogen Receptor β in the Brain: An Overview.” Front Endocrinol (Lausanne) 6: 160. - PMC - PubMed
    1. Acosta JI, Mayer L, Talboom JS, Tsang CW, Smith CJ, Enders CK and Bimonte-Nelson HA (2009). “Transitional versus surgical menopause in a rodent model: etiology of ovarian hormone loss impacts memory and the acetylcholine system.” Endocrinology 150(9): 4248–4259. - PMC - PubMed
    1. AMICO JA, ULBRECHT JS and ROBINSON AG (1987). “Clearance Studies of Oxytocin in Humans Using Radioimmunoassay Measurements of the Hormone in Plasma and Urine*.” The Journal of Clinical Endocrinology & Metabolism 64(2): 340–345. - PubMed
    1. Arnauld E, Bibene V, Meynard J, Rodriguez F and Vincent JD (1989). “Effects of chronic icv infusion of vasopressin on sleep-waking cycle of rats.” Am J Physiol 256(3 Pt 2): R674–684. - PubMed
    1. Arsenijevic Y, Dreifuss JJ, Vallet P, Marguerat A and Tribollet E (1995). “Reduced binding of oxytocin in the rat brain during aging.” Brain Res 698(1–2): 275–279. - PubMed

Publication types